Results 171 to 180 of about 678,190 (310)

Changes in frailty and incident risk of degenerative bone and joint diseases and their multimorbidity: a prospective cohort study. [PDF]

Front Public Health
Jin M, Liu J, Song X, Lei B, Su Y, Shi Z, Xu D, Yang B, Zhang D, Ma X, Li H, Chen Z, Li Z, Pang Y, Zhong Y, Xia M, Ju Y, Feng Z, Fan M, Jiang X.   +19 more
europepmc   +1 more source

SYPHILITIC JOINT DISEASE [PDF]

BMJ, 1903
openaire   +2 more sources

Formal and Informal Social Care in People With Rheumatic and Musculoskeletal Diseases: A Cross‐Sectional Multicenter Survey

Arthritis Care &Research, EarlyView.
Objective Rheumatic and musculoskeletal diseases (RMDs) are leading causes of physical disability, necessitating support with activities of daily living. This study describes social care received by patients with RMDs in two disparate regions of England: Salford (urban) and Norfolk (rural).
Mehreen Somro, Karen Durrant, William G. Dixon, John McBeth, Alex MacGregor, Max Yates, Jenny H. Humphreys   +6 more
wiley   +1 more source

Introduction to the 2025 "Chief Resident Grand Rounds" edition of the Bulletin of the Hospital for Joint Diseases. [PDF]

Bull Hosp Jt Dis (2013)
Habibi A, Kingery M.
europepmc   +1 more source

[Impact of surgical treatment of morbid obesity on joint diseases]. [PDF]

Probl Endokrinol (Mosk), 2023
Panevin TS, Zotkin EG, Lila AM.
europepmc   +1 more source

High Health Care Utilization Preceding Diagnosis With Juvenile Idiopathic Arthritis

Arthritis Care &Research, EarlyView.
Objective Although early diagnosis improves long‐term outcomes, patients with juvenile idiopathic arthritis (JIA) often experience prolonged, circuitous paths to diagnosis. To inform diagnostic improvement, we sought to characterize health care utilization in the year preceding diagnosis. Methods We identified 10,021 patients with an incident diagnosis
Anna Costello, Rui Xiao, Xuemei Zhang, Jahan Jazayeri, Irit R. Rasooly, Pamela F. Weiss   +5 more
wiley   +1 more source

Trace Elements-Role in Joint Function and Impact on Joint Diseases. [PDF]

Int J Mol Sci
Bryliński Ł, Brylińska K, Woliński F, Sado J, Smyk M, Komar O, Karpiński R, Prządka M, Baj J.   +8 more
europepmc   +1 more source

Targeting CD44 Receptor Pathways in Degenerative Joint Diseases: Involvement of Proteoglycan-4 (PRG4). [PDF]

Pharmaceuticals (Basel), 2023
Qadri MM.
europepmc   +1 more source

Integrating Patient‐Reported Quality Measures in Systemic Lupus Erythematosus: Development of the American College of Rheumatology Implementation Guide

Arthritis Care &Research, EarlyView.
Objective To support high‐quality, patient‐centered care for systemic lupus erythematosus (SLE), the American College of Rheumatology (ACR) developed evidence‐based measures incorporating clinical and patient‐reported outcome measures (PROMs). Using the Consolidated Framework for Implementation Research (CFIR), we conducted semistructured interviews ...
Catherine Nasrallah, Cherish Wilson, Christine Hariz, Christie M. Bartels, Shanthini Kasturi, Wambui Machua, Amy Bennett, Kate Chiseri, Allison Plitman, Starla Hairston Blanks, April Jorge, Patti Katz, Jinoos Yazdany, Shivani Garg   +13 more
wiley   +1 more source

Cytosolic phospholipase A2 as a therapeutic target for degenerative joint diseases. [PDF]

Bone Res
Huang G, He C, Fu W, Bi J, Wang J, Wiznia DH, Liu CJ.   +6 more
europepmc   +1 more source